Discovery of (S)-2-Cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): A Novel, CNS Penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) Positive Allosteric Modulator (PAM)
Author(s) -
Lindsey C. Morris,
Kellie D. Nance,
Patrick R. Gentry,
Emily Days,
C. David Weaver,
Colleen M. Niswender,
Analisa D. Thompson,
Carrie K. Jones,
Chuck W. Locuson,
Ryan D. Morrison,
J. Scott Daniels,
Kevin D. Niswender,
Craig W. Lindsley
Publication year - 2014
Publication title -
journal of medicinal chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.01
H-Index - 261
eISSN - 1520-4804
pISSN - 0022-2623
DOI - 10.1021/jm501375c
Subject(s) - chemistry , exenatide , haloperidol , allosteric modulator , endogeny , allosteric regulation , catalepsy , pancreatic islets , insulin , pharmacology , stereochemistry , islet , biochemistry , receptor , endocrinology , diabetes mellitus , type 2 diabetes , medicine , dopamine
A duplexed, functional multiaddition high throughput screen and subsequent iterative parallel synthesis effort identified the first highly selective and CNS penetrant glucagon-like peptide-1R (GLP-1R) positive allosteric modulator (PAM). PAM (S)-9b potentiated low-dose exenatide to augment insulin secretion in primary mouse pancreatic islets, and (S)-9b alone was effective in potentiating endogenous GLP-1R to reverse haloperidol-induced catalepsy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom